A human pan-disease blood atlas of the circulating proteome
Science. 2025 Oct 9:eadx2678. doi: 10.1126/science.adx2678. Online ahead of print. ABSTRACT The human blood proteome provides a holistic readout of […]
PubMed
PubMed
PubMed
Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus
Expert Rev Clin Pharmacol. 2025 Oct 9. doi: 10.1080/17512433.2025.2573783. Online ahead of print. ABSTRACT INTRODUCTION: Pregnancy in women with systemic
PubMed
Rheumatology services in Aotearoa New Zealand-do they meet Arthritis New Zealand/New Zealand Rheumatology Association-endorsed service standards?
N Z Med J. 2025 Oct 10;138(1623):12-37. doi: 10.26635/6965.7105. ABSTRACT AIMS: To describe Health New Zealand – Te Whatu Ora
PubMed
Identification of shared key genes in Rheumatoid Arthritis and COVID-19 and their relevance as diagnostic biomarkers and with immune infiltration: New insights from bioinformatics analysis
PLoS One. 2025 Oct 9;20(10):e0333886. doi: 10.1371/journal.pone.0333886. eCollection 2025. ABSTRACT The interaction mechanism between Coronavirus Disease (COVID-19) and rheumatoid arthritis
PubMed
Behçet’s disease beyond the criteria: insights from a tertiary centre in Turkey
Clin Exp Rheumatol. 2025 Oct 6. doi: 10.55563/clinexprheumatol/h8mxc6. Online ahead of print. ABSTRACT OBJECTIVES: There are no pathognomonic findings for
PubMed
Efficacy and safety of tocilizumab in polyarteritis nodosa and adenosine deaminase 2 deficiency: a systematic literature review
Clin Exp Rheumatol. 2025 Oct 8. doi: 10.55563/clinexprheumatol/477rzo. Online ahead of print. ABSTRACT OBJECTIVES: There is a significant need for
PubMed
Silent but significant: subclinical cardiovascular changes in paediatric Behçet’s disease
Clin Exp Rheumatol. 2025 Oct 7. doi: 10.55563/clinexprheumatol/hepzdi. Online ahead of print. ABSTRACT OBJECTIVES: Behçet’s disease (BD) is a systemic,
PubMed
The presence of synovial inflammation and response to targeted therapies
Rheumatology (Oxford). 2025 Oct 9:keaf524. doi: 10.1093/rheumatology/keaf524. Online ahead of print. NO ABSTRACT PMID:41064956 | DOI:10.1093/rheumatology/keaf524
PubMed
Using Biologics in the Prevention of Anaphylaxis
Curr Allergy Asthma Rep. 2025 Oct 9;25(1):44. doi: 10.1007/s11882-025-01224-7. ABSTRACT PURPOSE OF REVIEW: Until recently, the management of anaphylaxis has
PubMed
The PROMIS-29 and SF-36 Quality of Life Scales Are Not Interchangeable in Systemic Sclerosis
Int J Rheum Dis. 2025 Oct;28(10):e70413. doi: 10.1111/1756-185x.70413. NO ABSTRACT PMID:41064968 | DOI:10.1111/1756-185x.70413
PubMed
Considerations for Treating Generalized Pustular Psoriasis (GPP): A Narrative Review
Dermatol Ther (Heidelb). 2025 Oct 9. doi: 10.1007/s13555-025-01535-7. Online ahead of print. ABSTRACT Generalized pustular psoriasis (GPP) is a rare,
PubMed
Trends in Self-reported Sleep Disturbance and Unhealthy Sleep Duration Among US Adults with Arthritis, 2005-2018
Int J Rheum Dis. 2025 Oct;28(10):e70430. doi: 10.1111/1756-185X.70430. NO ABSTRACT PMID:41064975 | DOI:10.1111/1756-185X.70430
PubMed
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2
J Exp Med. 2025 Dec 1;222(12):e20251146. doi: 10.1084/jem.20251146. Epub 2025 Oct 9. ABSTRACT The S2 subunit of the severe acute
PubMed
Long-Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
Int J Rheum Dis. 2025 Oct;28(10):e70431. doi: 10.1111/1756-185X.70431. ABSTRACT BACKGROUND: Intensive immunosuppressive therapy (IIT) is recommended for PAH associated with
PubMed
IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis
JAMA Netw Open. 2025 Oct 1;8(10):e2536691. doi: 10.1001/jamanetworkopen.2025.36691. NO ABSTRACT PMID:41066128 | DOI:10.1001/jamanetworkopen.2025.36691
PubMed
Asymmetric Sacroiliitis as the Presenting Manifestation of Axial Gout
Int J Rheum Dis. 2025 Oct;28(10):e70429. doi: 10.1111/1756-185X.70429. NO ABSTRACT PMID:41064983 | DOI:10.1111/1756-185X.70429
PubMed
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study)
J Diabetes Investig. 2025 Oct 9. doi: 10.1111/jdi.70173. Online ahead of print. ABSTRACT INTRODUCTION: The renoprotective effects of luseogliflozin, a
PubMed
Tongue feature-based model for assessing disease activity in patients with rheumatoid arthritis
Front Pharmacol. 2025 Sep 23;16:1651557. doi: 10.3389/fphar.2025.1651557. eCollection 2025. ABSTRACT INTRODUCTION: Tongue features, which are emerging imaging-based biomarkers, have been
PubMed
Long-term outcomes of juvenile dermatomyositis
J Eur Acad Dermatol Venereol. 2025 Oct 9. doi: 10.1111/jdv.70103. Online ahead of print. NO ABSTRACT PMID:41065123 | DOI:10.1111/jdv.70103
PubMed
Novel insights into the hepatoprotective mechanisms of SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Front Pharmacol. 2025 Sep 23;16:1649630. doi: 10.3389/fphar.2025.1649630. eCollection 2025. ABSTRACT The sodium-glucose cotransporter (SGLT)2 inhibitor empagliflozin (EMPA) is a hypoglycemic
PubMed
Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice
J Am Heart Assoc. 2025 Oct 9:e042608. doi: 10.1161/JAHA.125.042608. Online ahead of print. ABSTRACT BACKGROUND: In children born at high
PubMed
Identification of shared biomarkers and potential therapeutic targets for antiphospholipid syndrome and recurrent miscarriage by integrated bioinformatics analysis and machine learning
Front Med (Lausanne). 2025 Sep 23;12:1639277. doi: 10.3389/fmed.2025.1639277. eCollection 2025. ABSTRACT BACKGROUND: Antiphospholipid syndrome (APS) is a group of clinical
PubMed
Ozoralizumab in rheumatoid arthritis: a novel Fc-free anti-TNF agent with serology-independent efficacy
Rheumatology (Oxford). 2025 Oct 9:keaf526. doi: 10.1093/rheumatology/keaf526. Online ahead of print. NO ABSTRACT PMID:41065429 | DOI:10.1093/rheumatology/keaf526
PubMed
Double positivity for anti-dsDNA and anti-Sm antibodies represents higher disease activity in systemic lupus erythematosus
Ther Adv Musculoskelet Dis. 2025 Oct 6;17:1759720X251379588. doi: 10.1177/1759720X251379588. eCollection 2025. ABSTRACT BACKGROUND: Several studies have shown that anti-dsDNA and
PubMed
Reply to: “HPV Vaccination and Autoimmune Diseases: Age- and Valency-Specific Benefits with Critical Methodological Gaps”
QJM. 2025 Oct 9:hcaf231. doi: 10.1093/qjmed/hcaf231. Online ahead of print. NO ABSTRACT PMID:41065496 | DOI:10.1093/qjmed/hcaf231
PubMed
Recurrent Huge Aortic Aneurysm, Myocardial Infarction, and Aortic Insufficiency in a Patient With Longstanding Behcet’s Disease: A Case Report of a Rare Triple Presentation
Clin Case Rep. 2025 Oct 6;13(10):e71060. doi: 10.1002/ccr3.71060. eCollection 2025 Oct. ABSTRACT Behçet’s disease is a systemic inflammatory disorder with
PubMed
The effectiveness and safety of subcutaneous methotrexate injection in Japanese patients with rheumatoid arthritis in a real-world setting
Mod Rheumatol. 2025 Oct 9:roaf093. doi: 10.1093/mr/roaf093. Online ahead of print. ABSTRACT OBJECTIVES: To clarify the effectiveness and safety of